Posts

The data are unambiguous, and they are troubling. Across Sub-Saharan Africa, Demographic and Health Survey (DHS) data consistently show that fewer than a quarter of children aged 6–23 months meet the minimum acceptable diet indicator - the composite measure that captures whether a child receives both adequate dietary diversity and adequate meal frequency on a given day. In the 2019 Ethiopia DHS, only 8% of children in this age group met the minimum acceptable diet threshold. In Nigeria, the 2018 DHS recorded 4%. In Mali, a figure barely above 5%. These numbers represent not edge-case inadequacy but the systematic failure of transitional diets across the continent during the period of greatest developmental vulnerability in human life.

In Sub-Saharan Africa, the estimated prevalence of neural tube defects (NTDs) ranges from 1 to 10 per 1,000 live births across different regions - figures that are broadly two to five times higher than those observed in countries where mandatory folic acid fortification of staple foods has been in place for over two decades.¹ In the United States, mandatory fortification of wheat flour introduced in 1998 was followed by a 26–36% reduction in NTD-affected pregnancies; in Canada, the corresponding decline exceeded 40%.² The contrast is sharp. Across most of SSA, fortification programmes either do not exist, are voluntary rather than mandatory, or achieve coverage too partial to generate population-level reductions in NTD prevalence. The result is a largely preventable burden of spina bifida, anencephaly, and encephalocele that falls disproportionately on women with the least access to periconceptional supplementation.

In 1902, the British colonial administration in Uganda mobilised one of the most ambitious forced population relocations in the history of African public health. Alarmed by the explosive spread of sleeping sickness (Human African Trypanosomiasis) along the northern shores of Lake Victoria, where an estimated 250,000 people had died in under a decade, Sir Hesketh Bell ordered the evacuation of roughly 30,000 people from a tsetse-infested lakeshore belt stretching hundreds of miles. Villages were burned. Fishing communities that had sustained themselves across generations were dismantled and driven inland. The logic was epidemiological: remove the human reservoir from the vector’s habitat. The method was coercive, the humanitarian cost enormous, and the results decidedly mixed. Yet the episode encapsulates something essential about the history of public health in Africa: interventions frequently reflected the priorities of administrations far removed from the populations they claimed to protect, and the infrastructure built around them carried contradictions that would outlast colonial rule by generations.

When Cicely Williams published her 1933 paper in the Archives of Disease in Childhood describing a syndrome she had observed in Ghanaian children characterised by oedema, skin depigmentation, fatty liver, and growth failure, she named it “kwashiorkor” - the word used by the Ga people of the Gold Coast to describe the disease suffered by a child displaced from the breast by a new sibling. Williams had identified what would eventually be classified as the most severe protein-deficient form of protein-energy malnutrition, a condition that would occupy nutritional science, paediatric medicine, and global health policy for the following nine decades. Her observations predated the coinage of the term “protein-energy malnutrition” itself - that came in the 1960s - but they established the epidemiological reality that continues to shape health outcomes across Sub-Saharan Africa: that the consequences of inadequate dietary protein and energy are not merely matters of weight and height, but of immune function, organ integrity, brain development, and survival.

During the 2011 Horn of Africa famine, UNICEF estimated that over 320,000 children in Somalia alone were acutely malnourished, with global acute malnutrition (GAM) rates in some districts of Bakool and Lower Shabelle exceeding 30 per cent - well above the emergency threshold of 15 per cent. That crisis, and the recurrent food emergencies of the Sahel that have followed each year since, have forced a sustained reckoning with how the international health community defines, identifies, and treats child wasting. This article reviews the clinical and epidemiological dimensions of wasting, distinguishes it from the longer shadow cast by stunting, and examines the evidence base for community-based management of acute malnutrition (CMAM) as the dominant treatment model across Sub-Saharan Africa.

The history of protein in global nutrition policy is, in no small measure, the history of a scientific overcorrection. For much of the mid-twentieth century, protein deficiency was regarded as the defining nutritional catastrophe of the post-colonial developing world - a condition so pervasive that a dedicated international effort, the Protein Advisory Group of the United Nations, was convened to address what was confidently called the “protein gap.” The clinical anchor of this alarm was kwashiorkor, the severe acute malnutrition syndrome first described systematically by Cicely Williams in 1935 in children presenting with oedema, skin lesions, and growth arrest following weaning. The name itself derives from the Ga language of coastal Ghana - meaning, roughly, “the sickness the child gets when displaced from the breast” - and the condition became the face of third-world malnutrition in the popular and scientific imagination alike.

Consider two health workers presenting findings from the same community in northern Ghana. The first reports that 38% of women of reproductive age have iron deficiency anaemia - a figure drawn from a cross-sectional survey conducted during the dry season, when dietary diversity is lowest and the pool of untreated cases has accumulated over months. The second reports that the rate of new anaemia diagnoses in the antenatal clinic is 14 per 100 woman-years of observation - a figure drawn from longitudinal surveillance that tracked women from first antenatal visit through delivery. Both numbers describe the same underlying condition in overlapping populations. They are not comparable, they are not interchangeable, and they address quite different policy questions. The first is a prevalence estimate; the second is an incidence rate. Understanding what each measures, how each is calculated, and when each is appropriate is one of the foundational competencies of epidemiological practice.

In the early 1960s, researchers in Cebu, the Philippines, began tracking a group of pregnant women through childbirth and into the early lives of their children. Over the following two decades, the Cebu Longitudinal Health and Nutrition Survey collected dietary recall data, anthropometric measurements, household asset information, and, in time, cognitive assessments for the index children as they moved into adolescence. What the dataset eventually demonstrated was at once obvious and profound: low-birthweight infants who also experienced linear growth faltering in the first two years of life carried measurably reduced cognitive capacity, lower school attainment, and reduced adult economic productivity. These were associations that no cross-sectional survey could have confirmed, because they depended on the temporal sequence - the exposure had to precede the outcome by years, sometimes decades. The Cebu study, later incorporated into the COHORTS consortium, became one of the most-cited bodies of evidence for early-life nutrition investment ( Victora et al., 2008 ).

In August 2014, health authorities in Guinea detected an unusual cluster of haemorrhagic fever cases in the south-eastern prefecture of Guéckédou. Within weeks, investigators from the Ministry of Health and the WHO had fanned out across villages, interviewing the sick and the bereaved, mapping contacts, tracing chains of transmission, and testing blood samples. What they uncovered - a zoonotic spillover of Ebola virus from a forest bat, amplified through funeral rites that brought mourners into direct contact with highly infectious bodies - was the opening chapter of the worst Ebola epidemic in recorded history. By the time the West African outbreak was declared over in 2016, more than 11,000 people had died across Guinea, Sierra Leone, and Liberia. The investigation that unravelled the source, the transmission dynamics, and the effective reproduction number was epidemiology at its operational core: a discipline built on the systematic study of how, where, and why disease occurs in populations.

In communities of the Democratic Republic of Congo where endemic iodine deficiency has persisted for generations, neurological cretinism - characterised by profound intellectual disability, deaf-mutism, and spastic diplegia - affects up to 10% of the population in the most severely affected inland villages. Even among children who appear clinically normal in these same communities, intelligence quotient (IQ) scores measured in controlled studies run 10–15 points below those of iodine-replete comparison populations ( Zimmermann, 2009 ). That invisible IQ deficit, unaccompanied by any visible neck swelling or recognisable syndrome, is the central paradox of iodine deficiency disorders (IDD): the most consequential damage occurs precisely where it cannot be seen.